Literature DB >> 10575101

N-ethylmaleimide selectively blocks presynaptic GABA-B autoreceptor but not heteroreceptor-mediated inhibition in adult rat striatal slices.

K D Phelan1.   

Abstract

Intracellular recording techniques were used in slices of adult rat striatum to compare the sensitivity of presynaptic gamma-aminobutyric acid type B (GABA-B) autoreceptor and heteroreceptor-mediated inhibition to the sulfhydryl alkylating agent, N-ethylmaleimide (NEM). NEM (100 microM) alone had no significant effect on resting potential or input resistance and did not consistently effect stimulus-evoked responses. Treatment of slices with NEM for up to 1 h, either in the presence or the absence of the GABA-B receptor-specific agonist, baclofen (BAC; 100 microM), completely blocked the BAC-induced depression of inhibitory, but not excitatory, postsynaptic potentials. This differential sensitivity to NEM alkylation suggests that in the adult rat striatum, the presynaptic GABA-B autoreceptors and heteroreceptors may exhibit distinct receptor-effector coupling mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10575101     DOI: 10.1016/s0006-8993(99)02105-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Depression of glutamate and GABA release by presynaptic GABAB receptors in the entorhinal cortex in normal and chronically epileptic rats.

Authors:  Sarah E Thompson; Goher Ayman; Gavin L Woodhall; Roland S G Jones
Journal:  Neurosignals       Date:  2007-01-11

2.  Modeling Starburst cells' GABA(B) receptors and their putative role in motion sensitivity.

Authors:  Norberto M Grzywacz; Charles L Zucker
Journal:  Biophys J       Date:  2006-04-28       Impact factor: 4.033

3.  Compartmental localization of gamma-aminobutyric acid type B receptors in the cholinergic circuitry of the rabbit retina.

Authors:  Charles L Zucker; James E Nilson; Berndt Ehinger; Norberto M Grzywacz
Journal:  J Comp Neurol       Date:  2005-12-19       Impact factor: 3.215

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.